Skip to content

Feasibility and Effectiveness of Virtual Reality & Use of Body Weight Support Treadmill Training in Parkinson's Disease

Feasibility and Effectiveness of Virtual Reality and the Use of Body Weight Support Treadmill Training in Parkinson's Disease: an Explorative Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02516644
Enrollment
20
Registered
2015-08-06
Start date
2015-02-28
Completion date
2018-12-31
Last updated
2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson Disease, Mobility, Balance, Virtual Reality, treadmill training

Brief summary

The primary hypothesis of the investigators is that a virtual reality system combined with physical activity provided on a body weight support treadmill training would change clinical parameters of balance and mobility in people with Parkinson's Disease

Interventions

BEHAVIORALVirtual Reality

12 sessions of 1 hour (30 min of virtual reality and 30 min of aerobic exercise with treadmill training): three times a week over four weeks

BEHAVIORALConventional Therapy

12 sessions of 1 hour of conventional physiotherapy: three times a week over four weeks

Sponsors

University Hospital of Ferrara
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 80 Years
Healthy volunteers
No

Inclusion criteria

* idiopathic Parkinson Disease diagnosis * age under 80 years * severity of disease rated 2 or 3 at Hoehn & Yahr scale

Exclusion criteria

* impaired cognitive functioning: score less than 24 on the Mini Mental State Examination * neurologic conditions in addition to Parkinson Disease that may affect motor function and other medical conditions likely to interfere with the ability to safely complete the study protocol * severe Levodopa dyskinesia * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Six-Minute Walking Testup to weeks 16The walking endurance is measured with the Six-Minute Walking Test. Subjects are instructed to walk up and down as far as possible a 22m walkway in six minutes without encouragement, with the possibility to slow down and rest if necessary.

Secondary

MeasureTime frameDescription
Time Up and Go Testweeks: 0,4, 16Subjects will be given verbal instruction to stand up from a chair, walk 3 meters, cross a line marked on the floor, turn around, walk back, and sit down. A study staff member will guard the subject during the test. Subjects will perform 3 trials and the time it takes to perform each trial will be recorded with a stopwatch.
10 meter walk testweeks: 0,4, 16Assesses walking speed in meters per second over a short duration
Berg Balance Scaleweeks: 0,4, 16This is an assessment scale of ability to maintain balance, or statically or while performing functional movement, including 14 observable tasks common to everyday life measured on a 5 point ordinal scale.
Postural sway (Center of pressure (COP) trajectories)weeks: 0,4, 16Center of pressure (COP) trajectories
Metabolic measurements by Near infrared spectroscopyweeks: 0,4, 16Near InfraRed Spectroscopy (NIRS) is a noninvasive, portable technique for ambulatory or remote monitoring of human motor-cortex oxygenation changes in response to motor tasks
Unified Parkinson's Disease Rating Scaleweeks: 0,4, 16It is a comprehensive assessment designed to monitor the burden and extent of Parkinson's disease across the longitudinal disease course and provide a clinical endpoint in therapy trials.

Countries

Italy

Contacts

Primary ContactSofia Straudi, MD
s.straudi@ospfe.it+390532238720

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026